Sublingual Misoprostol Versus Placebo to Reduce Blood Loss During Elective Cesarean Delivery : A Randomized Controlled Study

NCT03140033 Phase 2 UNKNOWN

Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery : A Randomized Controlled Trial

Details

Lead sponsor	Ain Shams Maternity Hospital
Phase	Phase 2
Status	UNKNOWN
Enrolment	158
Start date	2016-07
Completion	2017-05

Conditions

• Hemorrhage Postpartum

Interventions

• Misoprostol Oral Tablet
• Ranitidine Oral Tablet

Primary outcomes

• Blood loss during cesarean sections — through study completion, an average of 1 year
  Blood loss will be estimated by the anesthesiologist Using soaked towels and suction set after delivery of placenta

Countries

Egypt